Xu Diyong 4
4 · Q32 Bio Inc. · Filed Oct 27, 2025
Insider Transaction Report
Form 4
Q32 Bio Inc.QTTB
Xu Diyong
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-10-23+53,521→ 53,521 totalExercise: $2.80Exp: 2035-10-22→ Common Stock (53,521 underlying)
Footnotes (2)
- [F1]The shares underlying this option shall vest and become exercisable in full upon the earlier of (i) October 23, 2026 or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service on such vesting date.
- [F2]Pursuant to an agreement with OrbiMed Advisors LLC and OrbiMed Capital GP VII LLC, the Reporting Person is obligated to transfer any securities issued under any such stock options or other awards, or the economic benefit thereof, to OrbiMed Advisors LLC and OrbiMed Capital GP VII LLC, which will in turn ensure that such securities or economic benefits are provided to OrbiMed Private Investments VII, LP.